SK3372003A3 - Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same - Google Patents

Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same Download PDF

Info

Publication number
SK3372003A3
SK3372003A3 SK337-2003A SK3372003A SK3372003A3 SK 3372003 A3 SK3372003 A3 SK 3372003A3 SK 3372003 A SK3372003 A SK 3372003A SK 3372003 A3 SK3372003 A3 SK 3372003A3
Authority
SK
Slovakia
Prior art keywords
pyrimidin
formula
thieno
cooh
solvates
Prior art date
Application number
SK337-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Rochus Jonas
Hans-Michael Eggenweiler
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK3372003A3 publication Critical patent/SK3372003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK337-2003A 2000-09-01 2001-08-03 Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same SK3372003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10042997A DE10042997A1 (de) 2000-09-01 2000-09-01 Thienopyrimidine
PCT/EP2001/008998 WO2002018389A2 (de) 2000-09-01 2001-08-03 Thienopyrimidine

Publications (1)

Publication Number Publication Date
SK3372003A3 true SK3372003A3 (en) 2003-07-01

Family

ID=7654560

Family Applications (1)

Application Number Title Priority Date Filing Date
SK337-2003A SK3372003A3 (en) 2000-09-01 2001-08-03 Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same

Country Status (21)

Country Link
US (1) US6780867B2 (es)
EP (1) EP1351962B1 (es)
JP (1) JP4927299B2 (es)
KR (1) KR20030032000A (es)
CN (1) CN1620458A (es)
AR (1) AR034148A1 (es)
AT (1) ATE291025T1 (es)
AU (2) AU2001293719B2 (es)
BR (1) BR0113582A (es)
CA (1) CA2420894C (es)
CZ (1) CZ2003794A3 (es)
DE (2) DE10042997A1 (es)
ES (1) ES2238481T3 (es)
HU (1) HUP0303677A2 (es)
MX (1) MXPA03001773A (es)
NO (1) NO20030948D0 (es)
PL (1) PL360298A1 (es)
RU (1) RU2003108860A (es)
SK (1) SK3372003A3 (es)
WO (1) WO2002018389A2 (es)
ZA (1) ZA200302513B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
CN100343258C (zh) * 2001-04-30 2007-10-17 美国拜尔公司 新的4－氨基－5,6－取代的噻吩并[2,3－d]嘧啶化合物
FR2988722B1 (fr) 2012-04-03 2014-05-09 Sanofi Sa Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
EP1351962B1 (de) 2005-03-16
WO2002018389A3 (de) 2003-07-03
US6780867B2 (en) 2004-08-24
DE10042997A1 (de) 2002-03-14
ES2238481T3 (es) 2005-09-01
KR20030032000A (ko) 2003-04-23
CZ2003794A3 (cs) 2003-06-18
CN1620458A (zh) 2005-05-25
ATE291025T1 (de) 2005-04-15
HUP0303677A2 (hu) 2004-04-28
MXPA03001773A (es) 2003-06-04
NO20030948L (no) 2003-02-28
PL360298A1 (en) 2004-09-06
BR0113582A (pt) 2003-07-15
JP2004519426A (ja) 2004-07-02
CA2420894A1 (en) 2003-02-27
AU2001293719B2 (en) 2007-03-01
JP4927299B2 (ja) 2012-05-09
RU2003108860A (ru) 2004-09-20
NO20030948D0 (no) 2003-02-28
EP1351962A2 (de) 2003-10-15
CA2420894C (en) 2010-03-30
WO2002018389A2 (de) 2002-03-07
ZA200302513B (en) 2004-08-24
DE50105652D1 (en) 2005-04-21
AR034148A1 (es) 2004-02-04
US20030187260A1 (en) 2003-10-02
AU9371901A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
US6495554B2 (en) Thienopyrimidines
SK50299A3 (en) Thienopyrimidine with phosphodiesterase v inhibiting effect
US20040034040A1 (en) Use of thienopyrimidines
AU743230B2 (en) Condensed thienopyrimidines with phosphodiesterase-V inhibiting action
SK3132002A3 (en) Thienopyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions comprising them
SK18222001A3 (sk) Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
US20040077664A1 (en) Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
SK7592003A3 (en) Use of pyrazolo[4,3-D]pyrimidines
SK3372003A3 (en) Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same
US20040023991A1 (en) Use of pyrazolo[4,3-d]pyrimidines
SK3322002A3 (en) Use of thienopyrimidines

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure